Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Prescription Drugs > Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals)
Category
Pharmaceutical (4988)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (561)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals)

Published by Technical Insights, Inc.
Published June, 2008 Product code 70270
Content info  
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) published by Technical Insights, Inc. in June, 2008. This report price starts from US $ 6500.

Introduction

Abstract

This research service analyzes the emerging trends in cancer therapies with respect to small molecule drugs and biologicals.

Table of Contents

1. EXECUTIVE SUMMARY

Scope and Methodology

  • Scope and Segmentation
  • Methodology

Industry Overview

  • An Overview of AntiCancer Therapeutics Industry
  • Key Findings

2. TECHNOLOGY TREND AND ADOPTION FACTOR ANALYSIS

Technology Trends in Cancer Therapies

  • Emerging Trends in Anticancer Therapeutic Approaches-- Diagnostics; Therapeutics; and Drug Delivery
  • Analysis of Potential Opportunities for Cancer Research

Strategic Analysis and Recommendations

  • Growth Accelerating Factors for Anticancer Drug Therapies
  • Growth Restraining Factors for Anticancer Therapies
  • Strategic Recommendations
  • Technologies Impacting Future of Cancer Therapy
  • Cancer Research Funding Sources
  • Corporate Mergers and Acquisitions

3. GLOBAL DEVELOPMENTS IN CANCER THERAPIES

Noteworthy Developments in Corporate Sector

  • Kinase Inhibiing Oral Drug to Treat GIST and Renal Cell Carcinoma
  • VEGF Inhibitor Drug Effectively Treats Metastatic Breast Cancer
  • Dual Action Heparan Sulphate Mimetic for Hepatocellular Carcinoma
  • Unique Technology with Multiple Applications for Cancer Diagnosis and Therapy
  • Next Generation Small Molecule Drug for Peripheral T-cell Lymphomas
  • Cancer Killing Virus Technology to Treat Metastatic Melanoma
  • Automated FISH Technology for Cancer Diagnosis
  • Novel Technology that Overcomes Immune Tolerance to Self Antigens in Cancer and Immunological Diseases
  • Novel Technology Platform for Discovery of Novel Class of Cancer Therapeutics
  • Ground Breaking Liposomal Drug Delivery Technology for Cancer Therapy
  • Disease Specific Microarray for the Development of Diagnostic and prognostic Tests for Cancer
  • Novel Therapy to Treat Malignant Glioma
  • DNA Interference Drug to Treat Cancer and Genetic Diseases
  • Personalized Cancer Diagnostic Test Aids the Selection of Chemotherapeutic Drugs

Noteworthy Developments in Academia

  • Discovery of Telomerase Related Proteins Raises Hopes of Antitumor Therapy
  • Nanoworms Enable Tumor Targeting and Diagnostic Imaging of Cancers

4. INTELLECTUAL PROPERTY SCENARIO AND KEY INDUSTRY PARTICIPANTS

Patent Details

  • Corporate Sector
  • Academic Sector

Contact Details

  • Industry Participants
  • University and Academia

5. DECISION SUPPORT DATABASE

Decision Support Tables

  • Number of Biotech Companies (2002 to 2012)
  • Venture Capital Investment in Biotechnology (2002 to 2012)
  • Incidence of Breast Cancer (2002 to 2012)
  • Incidence of Prostate Cancer (2002 to 2012)
  • Incidence of Bladder Cancer (2002 to 2012)
  • Incidence of Liver Cancer (2002 to 2012)
Back to Top